- Contractors
- Mapp Biopharmaceutical, Inc.
Mapp Biopharmaceutical, Inc.
Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)
Mapp Biopharmaceutical has 9 federal contracts of $100,000 or more active since October 2023, with $492M obligated, from 2 agencies. 4 are still running, 1 ending within 18 months.
- Contracts
- 9 since FY2024$491,942,315 obligated, contracts of $100,000 or more
- Running now
- 4 contracts2 ended in the last 12 months
- Biggest customer
- Office of Assistant Secretary for Preparedness and Response$491M on 7 contracts
- Main industry
- Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714
- UEI
- M9V9QTHR1H28Unique entity ID in SAM.gov
- Source
- USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC
Contracts by start year
Show as table
| Fiscal year | Contracts |
|---|---|
| FY2020 | $16,413,163 |
| FY2021 | $601,142 |
| FY2022 | $376,128,850 |
| FY2024 | $5,626,972 |
| FY2025 | $110,500 |
Running contracts
Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.
| Contract | Obligated | Ends | State |
|---|---|---|---|
| Mapp Eap - Igf::Cl::Igf for Other Functionsexpanded Access Protocol for ZmappOffice of Assistant Secretary for Preparedness and Response · HHSO100201600021C | $28,870,288 | Dec 31, 2026in 1 month | CA |
| Procurement of Therapeutics for Ebola, Sudan and Marburg VirusesOffice of Assistant Secretary for Preparedness and Response · 75A50122C00061 | $220,916,162 | Sep 30, 2030in 46 months | CA |
| This Cost-Plus-Fixed-Fee Contract With Mapp Biopharmaceutical, Inc. (Mapp or Contractor) Is for the Development of Mapp?s Therapeutic Intervention MBP091, As an Immunotherapy for the Treatment of…Office of Assistant Secretary for Preparedness and Response · 75A50122C00076 | $155,212,688 | Dec 31, 2032in 73 months | CA |
| Development of Medical Countermeasures Through Planned Clinical Trials and Outbreak PreparednessOffice of Assistant Secretary for Preparedness and Response · 75A50124C00003 | $5,626,972 | Dec 31, 2032in 73 months | CA |
End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.
Who they work for
| Agency | Amount, $M | Share |
|---|---|---|
| Office of Assistant Secretary for Preparedness and Response7 contracts | 491.2 | |
| Defense Health Agency2 contracts | 0.7 |
What they sell
| Industry | Amount, $M | Share |
|---|---|---|
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 4 contracts | 398.2 | |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 · 1 contract | 56.7 | |
| Research and Development in the Social Sciences and HumanitiesNAICS 541720 · 1 contract | 28.9 | |
| Research and Development in BiotechnologyNAICS 541711 · 1 contract | 7.5 | |
| Testing Laboratories and ServicesNAICS 541380 · 1 contract | 0.6 | |
| In-Vitro Diagnostic Substance ManufacturingNAICS 325413 · 1 contract | 0.1 |
Where the work is
| Place of work | Amount, $M | Share |
|---|---|---|
| California8 contracts | 491.3 | |
| Maryland1 contract | 0.6 |
Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.
Get new notices like Mapp Biopharmaceutical's work
New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.
Free. We use your email only for these alerts and never share it. Privacy